Total Funding
72
60
Total FundingGrant raised
Growth Score
-8 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
29205
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection.
- Daniel Silva Manzano: Co-Founder and CEOPast Role: Neoleukin Therapeutics, VP Head Of Research and Co-founder
David Shoultz: Co-Founder & COOPast Role: Bill & Melinda Gates Foundation, Director of Grantee and Partner Engagement
About the Company
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid,
sensitive, and inexpensive analytical assays.
Monod Bio was founded in 2021 and is headquartered in Seattle, Washington.
